… genital wart diagnoses rather than decreases in cervical cancer rates, as the time to development
of genital warts after infection with HPV … Human papilloma virus vaccines and their role …

… number of new cancers of the cervix, vulva, vagina, anus, penis, and … cervix, vulva, vagina,
and anus; and the annual number of genital warts cases attributable to 9-valent HPV vaccine …

… papillomavirus vaccination program, the management rate of genital warts in sexual health
clinics and private hospitals has decreased in women of vaccine-eligible age. However, most …

… human papillomavirus on HPV infections, anogenital wart … evidence about the effectiveness
of HPV vaccines in real-world … for anogenital warts by the type of vaccine administered, …

… . Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia:
analysis of national sentinel surveillance data. Lancet Infect Dis 2011;11:39–44.doi:10.1016/…

… the progression from HPV infection to cervical cancer or genital warts. The model was used
to estimate the difference in future costs and health effects of both HPV-vaccines separately. …

… latency period from HPV infection to cervical cancer; however, health care utilization for
anogenital warts (AGWs) provides an early indication of the program’s impact in preventing HPV-…

… and its impact, including on the prevalence of genital warts, … the effect of HPV vaccination
programs in indigenous … effect of the HPV vaccination program on diagnoses of genital warts in …

… papillomavirus (HPV) vaccination programme. Sex Transm Infect 2011; 87: 544–547. … genital
warts after the implementation of a national quadrivalent human papillomavirus vaccination …

… periods, in the incidence or prevalence of at least one HPV-related endpoint: HPV infection,
anogenital warts, and high-grade cervical lesions. We used random-effects models to derive …